IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure," "IceCure Medical" or the "Company

Agreement expands ProSense® commercialization in the Netherlands as cryoablation advances to Phase I

Patients are expected to enroll in the post-marketing study in the coming weeks, following approval

Patients are expected to enroll in the post-marketing study in the coming weeks, following approval

New review by leading U.S. experts highlights ProSense® FDA marketing authorization, updated America

New review by leading U.S. experts highlights ProSense® FDA marketing authorization, updated America

IceCure Medical Ltd (ICCM) Q2 2026 Earnings Call Transcript

Icecure Medical (NASDAQ:ICCM) reported quarterly losses of $(1.37) per share which beat the analyst

The Company is advancing commercial execution and expanding its U.S. commercial footprint through ap

Gainers AbCellera Biologics (NASDAQ:ABCL) shares increased by 8.2% to $7.5 during Friday's afte

Adventist Health Glendale is the first site able to enroll patients in the ChoICE Study after signin

CAESAREA, Israel, Aug. 5, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure," "IceC

 IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure," "IceCure Medical" or the "Compan

The petition by The Society of Interventional Oncology (SIO) includes adding criteria for patients a

Company signed agreement with the West Cancer Center & Research Institute, the first clinical site f

CAESAREA, Israel, July 14, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure," "Ice

Gainers OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-mark

Growing physician interest and commercial adoption for ProSense™ in Brazil's expanding intervent

Growing physician interest and commercial adoption for ProSense™ in Brazil's expanding interventiona

Gainers INVO Fertility (NASDAQ:IVF) shares moved upwards by 67.3% to $2.08 during Friday's regu

IceCure Medical (NASDAQ: ICCM) has officially regained compliance with Nasdaq's minimum bid pric

IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Compan

CAESAREA, Israel, June 25, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "Ice

Gainers Pulsenmore (NASDAQ:PLSM) shares moved upwards by 160.5% to $8.88 during Wednesday's reg

U.S. stocks rose, with Nasdaq up 50 points. KB Home (NYSE: KBH) reported strong Q2 results, shares j

Published in the International Journal of Surgery, globally ranked in the top three among surgery jo

Published in the International Journal of Surgery, globally ranked in the top three among surgery jo

U.S. stocks up with Dow Jones gaining 200+ points. AbbVie Inc. announced acquisition of Apogee Thera

Smith & Wesson (SWBI) shares rose in pre-market trading after posting strong Q4 results, beating

Major U.S. stock indexes closed lower on Wednesday, with the Dow Jones Industrial Average slipping 0

IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company

CAESAREA, Israel, June 17, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "Ice

IceCure Medical Ltd. (NASDAQ:ICCM) shares are soaring Wednesday after the company reported a 70% jum

IceCure Medical shares are soaring Wednesday after reporting a 70% jump in U.S. installs of its ProS

U.S. stocks up, Dow Jones gains 0.39%. NASDAQ rose 0.09%, S&P 500 up 0.11%. Industrials shares j

US stocks gain in morning trading, Dow up 0.1%. Tech sector leads gains, while communication service

Increase driven by FDA clearance, clinical guideline support, and increased physician demand. Signif

Increase driven by FDA clearance, clinical guideline support, and increased physician demand. Signif

U.S. stock futures rise, Nasdaq up 1%. Graham Corp shares down 8.7%. Other stocks declining in pre-m

Proactive Step to Regain Nasdaq Compliance as Part of the Company's Broader Capital Markets Stra

Proactive Step to Regain Nasdaq Compliance as Part of the Company's Broader Capital Markets Strategy

At the annual European Conference on Interventional Oncology, ICESECRET data presented demonstrated

At the annual European Conference on Interventional Oncology, ICESECRET data presented demonstrated

Maxim Group analyst Anthony Vendetti maintains Icecure Medical (NASDAQ:ICCM) with a Buy and lower

No Immediate Effect on Nasdaq Listing or Trading of the Company's Ordinary Shares CAESAREA, Israel,